Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–1 of 1 results
Advanced filters: Author: Lisa Rahbaek Clear advanced filters

  • A potent and selective inhibitor of KRASG12D, the most common mutant form of the KRAS oncoprotein, has anti-tumor efficacy in multiple pre-clinical cancer models, opening the possibility to therapeutically target this highly prevalent oncogenic driver.

    • Jill Hallin
    • Vickie Bowcut
    • James G. Christensen
    Research
    Nature Medicine
    Volume: 28, P: 2171-2182